Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation (NCT03734666) | Clinical Trial Compass
CompletedNot Applicable
Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation
United States67 participantsStarted 2019-01-14
Plain-language summary
The purpose of this study is to develop a treatment that can effectively help people reduce their alcohol use and quit smoking.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria Aim 1:
* 18 years of age or older
* Currently smoking 3 or more cigarettes per day for the past year.
* Carbon monoxide level \>/= 8 ppm(parts per million); should carbon monoxide level yield a result less than 8 ppm, participant will be asked to submit a urine sample to determine contine levels and the result must be \>/ level 3
* Participant must be motivated to quit smoking and decrease alcohol use within the next 60 days
* If male, consume \>/= 5 drinks and if female consume \>/= 4 drinks on at least 1 occasion in the past month
* Willing and able to attend the 8 weekly group sessions
* Valid home address in the Tampa Bay area
* Functioning telephone number
* Can speak, read and write in English
Inclusion Criteria Aim 2:
* 18 years of age or older
* Currently smoking 3 or more cigarettes per day for the past year.
* Motivated to quit smoking and decrease alcohol use within the next 60 days
* If male, consumes \>/= 5 drinks and if female consumes \>/= 4 drinks on at least 1 occasion in the past month
* Willingness and ability to attend 8 weekly video group sessions
* Willingness and ability to use an email account for study materials
* Valid address
* Functioning telephone number
* Can speak, read and write in English
Exclusion Criteria:
* Unable to wear nicotine patch
* Participants who have an active substance use disorder other than an alcohol use disorder
* Participants who have an active psychotic disorder
* Current use of tobacco cessation med…
What they're measuring
1
Aim 2: Number of Participants Scoring >3
Timeframe: End of Treatment at 8 Weeks
2
Aim 2: Rate of Recruitment of Eligible Participants
Timeframe: 20 weeks
3
Aim 2: Participant Retention
Timeframe: End of study at Week 16 Follow-up
4
Aim 2: Percentage of Participants That Completed Questionnaires
Timeframe: End of study at Week 16 Follow-up
Trial details
NCT IDNCT03734666
SponsorH. Lee Moffitt Cancer Center and Research Institute